World Orphan Drug Congress Europe 2020

November 2 - November 5
Loading Events

Strategy, advocacy and partnering for the orphan drug industry

World Orphan Drug Congress 2020
Panel: Optimising clinical development strategies for gene therapy.
Full panel to be confirmed.
Samantha Parker, Senior Vice President & Chief Patient Access Officer, Lysogene
Mathew Pletcher, Head of Rare Diseases, Roche
Christeen Moburg, Senior Director, Patient Advocacy, Sangamo Therapeutics

Details

Start:
November 2
End:
November 5
Website:
https://www.terrapinn.com/conference/world-orphan-drug-congress/index.stm

Venue

Virtual Meeting

Lysogene COVID-19 update

Get In Touch

Don’t hesitate to contact us if you need more help.